News New drugs boost Eli Lilly, ahead of animal health IPO Eli Lilly closed the second quarter with substantial revenue increase thanks to a strong performance from a group of recently-approved drugs.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
